Vascular access devices (VADs) like PIVCs, midlines, and PICCs are vital for patient care, but their impact on quality of life (QoL) isn’t well understood. This scoping review explored existing r...

Vascular access is vital in modern healthcare—but it remains a high-risk, high-cost procedure. Preventable harm, rapid technological change, and inconsistent practices continue to challenge clini...

Central line-associated bloodstream infections (CLABSIs) are among the most serious complications of central venous access devices (CVADs), causing harm to patients and burdening health systems. De...

Central venous access devices (CVADs) are critical for delivering cancer treatment in children, but they can lead to skin injuries that cause pain, distress, and device failure. This scoping review...

Central venous access devices (CVADs) are essential for delivering treatment to children with cancer. However, they carry a significant risk of complications that can delay therapy and impact outco...

Central venous catheters (CVCs) are essential in critical care, but their failure due to dressing disruption is a persistent issue—especially for jugular lines. The STICKY trial, a multicenter ra...